LOS ANGELES — The SEC claims in a federal complaint that Curative Biosciences fka Healthient concealed the sale of 29 million unregistered shares, from which its bosses diverted $4 million for themselves.
Subscribe to our free newsletters
Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.

